They develop an intelligent robot to detect and define skin cancer in real time and without contact

ALICANTE, 24 Sep. (EUROPA PRESS) -

The Generalitat Valenciana, through the Department of Innovation, Industry, Commerce and Tourism, has supported the development of a new intelligent robot for dermatological examination capable of assisting in the detection and delimitation of the main types of skin cancer using a technique automated that requires no contact and is completed in just a few seconds.

In the execution of this strategic project, named AD-DERMA, the company Mercé V. Electromedicina has participated together with the AINIA Technological Center. Both have had the support of the AVI and financing from the European Union within the framework of the Comunitat Valenciana FEDER program for the period 2021-2027.

Through this initiative, the aim is to make available to healthcare professionals a tool with greater autonomy, intelligence and versatility than the current solutions on the market, which do not facilitate the diagnosis of the most frequent and dangerous types of skin cancer, such as They are basal cell carcinoma and melanoma.

The new device will save time in the detection of these diseases, will reduce the health costs associated with consultation, diagnosis and intervention operations, and will also contribute to reducing waiting lists, as indicated by the Generalitat in a statement.

This new technology, which combines collaborative robotics, high spatial and spectral resolution photonic sensors and Artificial Intelligence, will assist specialists by automating explorations and digitizing the affected area. In this way, it will contribute to the early detection of skin cancer, a decisive factor in curing this disease.

In addition to the advantages it offers in the diagnosis phase, the robot has a relevant potential use in surgeries, since, by being able to delimit the affected area in real time, it can help remove the entire tumor tissue without the need. of second interventions.

Two partners have participated in the execution of this initiative, AINIA and Mercé V. Electromedicina, which, as a company that provides high-tech medical products and equipment, knows the needs, requirements and certifications that a medical product or device must meet, and the operation of the sales and supply chain.

For its part, the technology center has contributed its prior knowledge in the area of ​​health and diagnosis using photonic technologies in the field of dermatology, as well as its experience in the development and use of robotic technologies.

The two entities have collaborated with the Dermatology Service of the Valencian Institute of Oncology (IVO), where Dr. Onofre Sanmartín has coordinated the observational study to validate its effectiveness with real patients.

AD-DERMA is directly aligned with the challenges and solutions identified by the AVI Health specialist committee, which, among other I D i proposals, advocates the development of new assistive instruments and technologies to support surgery.

Likewise, the project falls within the main axes of the Intelligent Specialization Strategy of the Valencian Community, S3, coordinated by the Department of Innovation, Industry, Commerce and Tourism.